LOADING
Comparing Broadcom Inc (AVGO) and Merck & Company (MRK) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AVGO | MRK |
|---|---|---|
| Price | $381.89 | $123.75 |
| Change Today | -0.05% | +2.61% |
| Market Cap | $1.82T | $295.4B |
| P/E Ratio | 63.3 | 33.7 |
| Forward P/E | 32.9 | 23.6 |
| PEG Ratio | 0.69 | 5.56 |
| EPS | $6.04 | $3.55 |
| Revenue Growth (YoY) | 47.9% | 4.9% |
| Profit Margin | 38.9% | 13.6% |
| Return on Equity | 37.3% | 18.9% |
| Dividend Yield | 0.67% | 2.84% |
| Beta | 1.43 | 0.22 |
| 52-Week High | $494.18 | $123.33 |
| 52-Week Low | $260.73 | $74.18 |
| Volume | 162K | 72K |
Broadcom Inc is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Broadcom Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.